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Abstract
Monte Carlo models of proton therapy treatment heads are being used to improve beam delivery
systems and to calculate the radiation field for patient dose calculations. The achievable accuracy
of the model depends on the exact knowledge of the treatment head geometry and time structure,
the material characteristics, and the underlying physics. This work aimed at studying the
uncertainties in treatment head simulations for passive scattering proton therapy. The sensitivities
of spread-out Bragg peak (SOBP) dose distributions on material densities, mean ionization
potentials, initial proton beam energy spread and spot size were investigated. An improved
understanding of the nature of these parameters may help to improve agreement between
calculated and measured SOBP dose distributions and to ensure that the range, modulation width,
and uniformity are within clinical tolerance levels. Furthermore, we present a method to make
small corrections to the uniformity of spread-out Bragg peaks by utilizing the time structure of the
beam delivery. In addition, we re-commissioned the models of the two proton treatment heads
located at our facility using the aforementioned correction methods presented in this paper.
1. Introduction
The accuracy of the planning and delivery of spread-out Bragg peak (SOBP) proton beam
treatments is imperative since millimeter errors can lead to over-dosage of critical organs or
under-dosage of the tumor if tight margins are being used (Goitein M 1978, Urie et al 1983,
Urie et al 1986a, Urie et al 1986b, Hong et al 1996, Sisterson et al 1998). Monte Carlo
methods have been used in proton therapy to help improve the accuracy of proton treatments
(Paganetti et al 2004, Newhauser et al 2005, Paganetti 2006, Paganetti et al 2008, Titt et al
2008). The value of Monte Carlo simulations of proton treatments is realized by the accurate
characterization of the radiation field at the exit of the treatment head, which depends on the
ability to account for the synchronization of the proton beam with the treatment head
geometries in order to produce clinically acceptable SOBP dose distributions.
An SOBP dose distribution is produced by introducing materials along the proton beam path
to modify the range of a proton Bragg peak as a function of time within the treatment head.
This is usually done by the means of a range modulator wheel (MW). An illustration of a
typical treatment head arrangement and a MW is presented in Figure 1. A series of steps is
arranged on a MW track of increasing water-equivalent thickness to cause a pull back of
peaks as a function of time for a constant wheel rotation. The superposition of these
individual Bragg peaks creates a uniform SOBP dose distribution if the peaks are properly
weighted. Due to the strong dependence of scattering on proton energy, the physical
dimensions and materials of a track can only be optimized for a limited amount of ranges.
However, it is possible to modulate the beam current intensity in synchronization with the
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MW rotation to further optimize the beam weights thus reducing the number of required
tracks (Lu and Kooy 2006). Furthermore, it is possible to preferentially select the position
on the MW to stop the beam current producing a desired modulation width for an SOBP
dose distribution. This scenario is demonstrated in Figure 1b.
The accuracy of the SOBP dose distribution is contingent on the time-dependent integration
of both the treatment head configuration and the variable proton beam current. One
important question that remains to be answered is what are the sensitivities of Monte Carlo
models of SOBP proton therapy delivery systems to uncertainties in the beam-line
parameters? There are uncertainties related to each Monte Carlo code that reduce the
accuracy of the simulation. For example, the use of models to simplify transport during
Monte Carlo simulations varies among different codes (e.g. condensed history method).
Furthermore, the cross sections as well as their implementation may be subject to
uncertainties and may also vary between codes (Zacharatou Jarlskog et al 2008). These
uncertainties are not considered in this paper. Yet another source of uncertainty is produced
during the modeling process of the treatment head. Most current models attempt to correctly
model machine-specific components in the treatment head (i.e scattering components,
modulator wheels, apertures, and compensators) using manufacture blueprints (Paganetti et
al 2004, Newhauser et al 2005, Paganetti et al 2008, Titt et al 2008). Based on our
experience, it is not uncommon that information provided by the manufacturer on these
geometries is different than the real geometries in the commissioned treatment head. Not
only the geometrical position but also physics constants of various materials might be
uncertain. Uncertainties are also inherent in beam parameters because they are difficult to
precisely measure. Moreover, uncertainties may also originate from the lack of knowledge
on the arrangement of these materials as a function of time, even if the geometry and
materials of the treatment head components are correctly implemented and the beam
parameters are precisely known.
In this paper we investigate sensitivities of Monte Carlo models of SOBP proton therapy
delivery systems to uncertainties in beam-line parameters. We also indentify a methodology
to improve the accuracy of Monte Carlo models despite the aforementioned uncertainties.
Finally, as an example, we apply this methodology to perform the full commissioning of two
treatment head models representing gantries at the Francis H. Burr Proton Therapy Center at
Massachusetts General Hospital (MGH). Several proton beam therapy centers are now
operational or being planned and constructed, which promises the future need for Monte
Carlo modeling of proton beam therapy treatment heads. The methodology and results
presented in this paper will help accommodate the commissioning of new Monte Carlo
simulated treatment heads. In addition, it might be helpful for individuals or manufacturers
involved in designing proton therapy equipment.
2. Methods
2.1 Monte Carlo model of the proton beam treatment head
A detailed model of the Francis H. Burr proton beam treatment head was developed by
Paganetti et al (2004) using the Monte Carlo code Geant4. All relevant components in the
treatment head were modeled based on blueprints provided by the system manufacturer Ion
Beam Applications S.A. (IBA, Louvain-la-Neuve, Belgium). Four-dimensional simulation
of the dynamic components (i.e. range modulator wheel rotation) was fully implemented.
The implementation of the temporal variation of the beam current (i.e. beam current
modulation) was originally set to match the correct current modulation function in the
treatment control system (Paganetti et al 2004). We have defined in our Monte Carlo models
24 beam current modulation functions for gantry 1 and 18 beam current modulation files for
gantry 2. The beam current modulation corrections are incorporated in the treatment control
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system as well as in the Monte Carlo as look-up tables. A review of the nozzle design of this
Monte Carlo proton nozzle can be found in Paganetti et al (2004).
All simulations were performed in Geant4 version 9.0 using the treatment head model. The
snout size at the nozzle exit was set to 25 cm diameter for all fields. The depth dose curves
were calculated along the beams’ central axis in a simulated water phantom using a scoring
region radius of 3 cm and scoring depth of 0.1 cm. In order to achieve reasonable statistics
for the depth dose curves at least 1×106 initial protons were simulated for each range and
modulation width combination. All curves were calculated with enough protons so that the
statistical uncertainty of each dose value at a given depth was less than 1%. All relevant
physics processes were used for this study. Ionization and multiple scattered were handled
with the standard electromagnetic physics option in Geant4. Inelastic processes were
handled using the Binary cascade model. We chose to use a range cut of 0.05 mm for
secondary particle production.
2.2 Sensitivities of Monte Carlo models of SOBP proton therapy delivery systems to
uncertainties in beam-line parameters
Typically, a comparison of calculated SOBP dose distributions with measured data is done
to commission Monte Carlo models of proton therapy treatment heads. The three
fundamental characteristics of the SOBP dose distribution are range, modulation width, and
uniformity. If the proton beam and modulator wheel is properly synchronized and the
treatment head geometry is accurately modeled, the accuracy of these characteristics
depends solely on material and beam parameters in the treatment head including: densities,
mean ionization potentials, initial beam energy spread and beam spot size. The sensitivities
of SOBP dose distributions on these parameters were tested using Monte Carlo simulations.
Both full and partial SOBP dose distributions were simulated using prescribed ranges
representing each of the available options. Since both treatment heads are very similar in
design we will only refer to Gantry 1 for the sensitivity study.
2.2.1 Range Uncertainties—The range of a roton beam in a medium is primarily
governed by proton interactions with atomic electrons and usually described by the proton’s
rate of energy loss known as the stopping power, which can be determined by the well-
known Bethe-Bloch equation. Several components in the treatment nozzle impact the range
of protons in the treatment head including the first scatterer (FS), the MW, and second
scatterer (SS) as shown in Figure 1, with the latter two components forming a unique
combination for each option. These components are typically made of a combination of lead
and plastic and are always option-dependent. More details about composition of each of
these components are provided in Table 1. Note that for a given manufacturer it is unlikely
that the design of the MW varies between different proton therapy centers. The two
parameters in the Bethe-Bloch equation associated with possible uncertainties for predicting
the correct range are the density and the mean ionization potential, which is also known as
the I-value.
In this study, the densities and I-values were varied in Lexan, carbon and lead to test the
sensitivity of range on these parameters. The densities of these materials were varied by
±1% and ±5% while the I-values of these materials were varied by ±10% and ±20%. The
variations reflect the potential uncertainties in these parameters. Table 2 provides nominal
densities and I-values for the materials considered. The range of each dose distribution was
determined using the distal 90% of the SOBP. For these simulations, all eight options were
considered.
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2.2.2 Uniformity Uncertainties—The uniformity of an SOBP dose distribution depends
on the summation of the weighted Bragg peaks created by the integration of the MW and the
proton beam current. Thus, treatment head parameters may also influence the uniformity of
the SOBP dose distribution. Monte Carlo simulations allowed us to investigate the
sensitivities of the SOBP uniformity on pertinent beam parameters such as the initial proton
beam energy spread and spot size. These two parameters may directly influence the
uniformity of the SOBP dose distribution by modifying the weights of selected Bragg peaks
created by the MW without modifying the proton beam current. We hypothesized that
changing the energy spread should increase or decrease the peak-to-plateau ratio of the
pristine Bragg peaks that are constituents of an SOBP. In a similar manner, the beam spot
may also influence the peak-to-plateau ratio of pristine Bragg peaks. Depending on the
width of the MW step, the beam spot may cover more than one step. For these narrower
steps and non-uniform beam current modulation, increasing or decreasing the assumed spot
size will modify the weights of the pristine Bragg peaks and potentially influence the SOBPs
uniformity. However, the overall sensitivity of SOBP dose distributions on these parameters
has never been tested.
In our Monte Carlo model we define the weighted energy spread (ΔE/E) of the proton beam
entering the treatment head by a linear function that decreases with beam energy. Note, we
assume a Gaussian energy spread function ΔE. The assumption of a linear relationship is an
approximation, since one might expect a sharper increase at lower energies. At our facility,
the energy spread reaches its maximum at around 160 MeV due to the settings of the beam
absorber and beam shaping slits in the energy selection system at the cyclotron exit along
with the magnetic beam steering. The relationship between beam energy and energy spread
is not known accurately (probably within 20% uncertainty) as the beam’s energy spread is
not easy to measure. Six additional linear energy spread functions (ΔE/E) with different
slopes were defined to test the sensitivity of beam energy spread on SOBP uniformity. The
nominal energy spread equation along with the six modified equations are plotted in Figure
2. The percent change is reflected in the energy spread of the lowest energy point, i.e. 130
MeV. Similarly, beam spot size is measured at our facility using a segmented ionization
chamber at the treatment head entrance. The nominal beam spot size was defined by a
Gaussian function with a full-width-at-half-maximum (FWHM) of 0.65 cm.
The sensitivity of the uniformity on the energy spread and spot size was tested. The
uniformity was defined as the percent difference between the maximum and minimum dose
on the SOBP plateau region. Only the dose values between 5% and 95% of the SOBP
plateau region were considered to avoid the inclusion of statistical fluctuations near large
dose gradients. For a perfectly flat SOBP the percent change would obviously be zero. To
test the sensitivity of the uniformity on the energy spread we use the six linear equations
presented in Figure 2. Likewise, to test the sensitivity of the beam spot size on the SOBP
uniformity, the FWHM of the spot size was modified by ±5% and ±20%.
2.2.3. Modulation Width Uncertainties—A change in uniformity of an SOBP dose
distribution also impacts the modulation width. Therefore, in this study we also investigate
the sensitivity of modulation of the initial beam energy spread and spot size.
2.3 A correction method to improve SOBP uniformity using beam current modulation
optimization
In the previous section we discussed the potential limitation for accurately modeling SOBP
dose distributions produced by Monte Carlo models due to uncertainties in the treatment
head configuration. If there is a discrepancy between the measured and simulated range of
an SOBP dose distribution, it is possible to correct for this discrepancy by adjusting beam
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line material parameters (e.g. density) as long as these adjustments are within the tolerances
specified by the manufacturer. However, if the SOBP uniformity is inaccurate then a more
rigorous tuning method might be needed, since even a slight disagreement between the
modulator wheel rotation and beam current in the Monte Carlo model could result in non-
uniform SOBP dose distributions (Lu et al 2007). Interestingly, the latter can be
advantageous because the beam current modulation function can be slightly tuned in the
Monte Carlo model to obtain accurate SOBP dose distributions. The importance of
accounting for the time-dependent integration of treatment head geometry with beam current
in Monte Carlo treatment head models has been demonstrated (Paganetti et al 2004).
In the following discussion, a tuning method is presented that is based on concepts provided
in several previous papers on beam current modulation (Lu and Kooy 2006, Lu et al 2007,
Lu 2008). A general formulism that expresses the relationship between the depth dose
distribution D(x) and the beam current modulation function I(t) is given by,
(1)
where C(x,t) is the transformation representing the specific configuration of the treatment
head settings. The upper limit S in the integral is simply the stop time of the proton beam.
Equation (1) is the general form for the dose distribution at a given depth in terms of the
treatment head configuration and the beam current modulation function (Lu and Kooy
2006).
For this work we provide a specific from of equation (1) that defines the depth dose
distribution produced by measured pristine Bragg peaks in the actual treatment system as,
(2)
The function I0(t) was previously determined from measured pristine Bragg peaks during the
commissioning process of our facility using an in-house software called DoseTools (Lu and
Kooy 2006). We should note that measured data was taken in a water tank using a Markus-
type ionization chamber (Lu and Kooy 2006). Reports of uncertainties for measurements of
this type range from 2–4% (Newhauser et al 2002). Whereas, the depth dose distribution
produced by the Monte Carlo model using the same beam current modulation function can
be expressed by,
(3)
Using the aforementioned measured Bragg peaks it is possible to adjust the beam current
function in DoseTools to fit the same depth dose distribution that is produced by the Monte
Carlo model, i.e.,
(4)
We can now solve for an adjusted beam current function that can be used in the Monte Carlo
to produce the original (i.e. uniform) depth dose distribution,
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(5)
Using equations (2–5), a solution for the optimized Monte Carlo beam current function I2(t)
can be determined, i.e.
(6)
This expression for the optimized Monte Carlo beam current function should produce
uniform SOBP dose distributions for any treatment head arrangement. Obviously, one would
expect the difference between I0(t) and I2(t) to be small.
Commissioning was performed for our Monte Carlo models of the treatment heads in Gantry
1 and Gantry 2 to test the feasibility of this correction method. We compared the calculated
range, modulation width, and uniformity to the expected values for each sub option. For this
study we followed the tolerance levels defined by Engelsman et al (2009) for the range and
modulation width, with an additional criteria that considered the SOBP uniformity. The
tolerance defined for the range is between (prescribed range-1 mm) and (prescribed range+2
mm), which preferentially errs to higher dose to normal tissue. However, we have to subtract
1 mm because of an off-set from the treatment control system considering that the SOBP
range is typically 1 mm shorter than the range of the deepest peak within the SOBP leading
to a tolerance between (prescribed range-2 mm) and (prescribed range+1 mm). A tolerance
of prescribed width±3 mm was set for the modulation width at the proximal 98% isodose
level. A third criteria was set for the uniformity of the SOBPs. The uniformity tolerance on
the SOBP plateau was set to be between 0±2%, which follows the uniformity requirement
used at our facility. The nominal material parameter values presented in Table 2 were used
for commissioning.
3. Results and Discussion
3.1 Sensitivities of SOBP simulations to uncertainties in beam or material parameters in
the treatment head
3.1.1 Range Uncertainties—Figure 3 (a.) shows the absolute difference of the simulated
SOBP range to the measured (nominal) range as a function of changes in the density of
Lexan for eight of the deliverable options from the Monte Carlo model of the treatment
nozzle in Gantry 1. Slight changes in density clearly influence the range of the SOBP. In
addition, the sensitivity of the density changes is dependent on the option since each option
uses a unique combination of a FS, MW, and SS (see Table 1). For example, the MW track
for option A1, which is composed of a large amount of Lexan, is much more sensitive to
density changes compared to the MW track option A7, which is composed of only a small
amount Lexan. Figure 3 (b.) provides the absolute difference of the modified SOBP range to
the nominal range as a function of changes in the density of carbon. It appears that slight
changes in the density of carbon does not have a noticeable effect within the statistical
uncertainty of the Monte Carlo simulation. This can be attributed to the fact that carbon is
only present on the MW track of two options (A4 and A6) and the amount of carbon
material present on these tracks compared to other materials is insignificant. That is, the
water-equivalent thickness of carbon on the MW is much less than the water-equivalent
thickness of lead on the MW. Alternatively, changes in the density of lead have a much
more prominent effect on the range of the SOBPs, as can be seen in Figure 3 (c.). The
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relative influence of density change on SOBP range for each option is slightly greater for
Lexan compared to lead due to the larger areal density of Lexan along each track. In
addition, Lexan and lead are also located on the FS and SS in the treatment head. For
example, despite the fact that Lexan does not appear on the MW track for option A4, this
option is still sensitive to changes in the density of Lexan since it uses a SS that consists of a
large amount Lexan compared to other scattering material.
It has been reported that material density is a parameter that is prone to error when provided
in manufacturer blue prints of radiation therapy hardware (Sheikh-Bagheri and Rogers
2002). Density values for lead provided in the literature or given by vendors vary in value by
less than a few percent. Conversely, the densities of Lexan and carbon are generally more
inconsistent, mainly due to uncertainties inherent in the fabrication process of plastics.
Therefore, the variation in the density of lead, Lexan and carbon could influence the
accuracy of the Monte Carlo simulation. The range accuracy of a Monte Carlo model could
be improved by simply adjusting material densities within the beam line, as long as these
adjustments are within the tolerances provided by the manufacturer. Of course, requesting
smaller tolerances in the manufacturer specifications of material parameters would also help
improve the accuracy of the model.
Figure 4 provides the absolute difference of the simulated SOBP range to the measured
range as a function of change in the I-value of Lexan, carbon, and lead. Here we
demonstrate slight changes in the range due to I-value changes in beam line materials. Small
changes in the I-values do not significantly impact the range of the SOBP dose distribution
because the I-value is only defined in the denominator of the logarithmic term of the relative
stopping power formula. However, it appears that larger uncertainties may produce range
changes that are clinically significant. This finding may be important since, the largest
uncertainty in the stopping power for clinically used proton beam energies extends from the
I-value (Andreo 2009, Gottschalk 2010). I-values for all materials can be determined by
measurement or theoretical calculation. Typically, the I-value is adjusted to agree with
measurement for elements where data exists, and is interpolated, using theory as a guide,
where data does not exist. However, it is clear from the literature that theory and
measurement do not always agree, possibly due to binding effects (Ahlen 1980). In Ahlen
(1980), variations in published I-values are presented for most elements. Differences in
published I-values for given elements can exceed 10% in some cases (Ahlen 1980). Andreo
(2009) investigated the effect of variation in I-values of water on pristine Bragg peaks where
the uncertainties may exceed 15%. The author noted a shift in Bragg peaks of up to 5 mm.
Therefore, the beam line material I-values may also be altered within the reported tolerances
when tuning of a Monte Carlo model is needed. We would also like to emphasize that
improvements in the estimates of I-values for beam line materials would help to improve the
accuracy of the Monte Carlo model.
3.1.2 Uniformity and Modulation Width Uncertainties—The sensitivity of SOBP
uniformity on the initial energy spread was studied by modifying the linear equation that
defines ΔE/E as a function of beam energy at the treatment head entrance. Six different
linear ΔE/E equations were studied, which are provided in Figure 2. Figure 6 provides the
uniformity as a function of different percent changes in the beam energy spread formula. It
appears that a change in beam energy spread does not have a noticeable effect on the
uniformity of the SOBP. It is know that for individual peaks the peak-to-plateau ratio of the
pristine peak is influenced by the change in energy spread. For example, increasing the
energy spread decreases the peak-to-plateau ratio due to the broadening of the Bragg peak
(Paganetti et al 2004). However, for the realistic energy spread changes considered in this
paper the effect is too subtle to have a significant impact on the uniformity of the SOBP (as
shown in Figure 6).
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Figure 7 provides the uniformity of the SOBP dose distribution in different options as a
function of percent change in the FWHM of the beam spot size at the treatment head
entrance. Again, the beam spot size does not have a noticeable effect on the uniformity. The
beam spot size has little influence on deeper peaks due to the large step widths for these
peaks on the modulator wheel. For shallower peaks in the SOBP it is more likely that the
beam spot size will overlap multiple steps causing the pristine peaks to broaden. However,
similar to the effect of changes in beam energy spread of the beam on the SOBP dose
distribution, spot size effects on shallower peaks are too subtle to produce significant
changes to the uniformity of the SOBP. As a result, it appears that both beam energy spread
and spot size are poor candidates for correcting the uniformity of the SOBP produced by
Monte Carlo models. An alternative correction method is presented in the next section.
We were also unable to discern an effect of changes in spot sizes or energy spread under
consideration on the modulation width. Actually, this result is opposite than what we
originally hypothesized. For example, an increase in spot size gives more weight to the most
proximal Bragg peak relative to deeper peaks. It might even result in protons passing
through a step in the MW (towards steps with greater thicknesses) that would not be
normally exposed. Even if the effect of beam spot overlap cancels out with the summation
of Bragg peaks, this is not the case for the last step where a bigger spot size might involve
an additional step. A slight change in the weight of the peaks produced by these narrower
steps could produce a significant change in the modulation width because the slope of the
depth-dose distribution proximal to the SOBP is very flat. However, insensitivity of spot
size on modulation width might be due to the fact that our facility uses wheel steps with
relatively large width (360 degrees for one full set of steps as shown in Figure 1). Other
facilities might use propellers with multiple blades (e.g. 4 blades using just 90 degrees for a
full set of steps). This results in smaller step widths and would increase the effect of a
changing beam spot size considerably. Based on these observations we believe that the
uniformity is more sensitive to uncertainties in the modeling of the timing structure of the
treatment head.
3.2 Commissioning the Monte Carlo model by optimizing beam current modulation
functions
Using the methodology described in Section II.C., we optimized the beam current function
in the Monte Carlo model to correct for discrepancies between measured and simulated
SOBPs and improve the accuracy of our model. The improvements in the dose distribution
are presented in Figure 8 where distributions produced by the optimized beam current
modulation function are compared with those produced from the initial beam current
functions. We only present data for the middle energy ranges of each option in Gantry 1 and
for full modulation. However, since the beam current modulation functions are option
dependent we performed beam current modulation corrections for all 24 sub-options (beam
current modulation tables) in Gantry 1 and all 18 sub-options in Gantry 2.
It is important to note that the tuning procedure presented in this paper does not significantly
change the characteristics of the proton beam. In Figure 9 we present the energy distribution
of protons recorded at the exit of the treatment head using both I(t) old and I(t) new. Two
different options (i.e. A2 and A6) were chosen for this comparison. As demonstrated in the
figures there are only slight differences between the energy distributions produced by the
two different beam current modulation functions. One should make sure that the beam
characteristics are not significantly altered when applying this tuning procedure.
All commissioning results in terms of range, modulation width and uniformity for Gantry 1
are presented in Figures 10a–c illustrating how fine-tuning the beam current modulation
results in excellent agreement between simulated and measured clinical field parameters.
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Figure 10a plots the calculated ranges for each of the deliverable 24 sub-options. Also
shown is the range tolerance. The data for all sub-options are within the clinical tolerances.
Figure 10b shows the calculated modulation widths for each sub-option. The clinical
tolerance of 3 mm or 3% regarding the location of the 98% isodose level was satisfied for
each sub-option. Figure 10c shows the uniformity (in %) for each sub-option of Gantry 1.
Again, the uniformity of each dose distribution is within the clinical tolerance.
Similarly, the commissioning results for Gantry 2 are presented in Figures 11a–c. Here, for
one SOBP dose distribution, the Monte Carlo results predict a slight overshoot (Figure 11a).
Furthermore, there are two sub-options that have uniformities slightly greater than 4%
(Figure 11c). These discrepancies could not be corrected using beam current modulation.
This could be due to significant differences between the designed and built geometry for
treatment head devices used in these options. However, these slight differences in the
uniformity will cancel out when more than one field is used for treatment.
4. Conclusion
The purpose of this paper was to present methods that can be used to assist in the
development of Monte Carlo models of SOBP delivery systems. Monte Carlo models of
SOBP delivery systems can be used in treatment planning for challenging clinical cases. In
order to simulate the proton field generated by a treatment head in proton therapy, an
accurate model of the entire delivery system is required. Even if the modeling of the
treatment head is based on manufacturer’s blueprints, there are limitations in accuracy due
to uncertainties in the geometries and materials (i.e. based on manufacturer drawings of the
dimensions and positions of various objects as well as on material parameters) and beam
parameters (i.e. based on measurements). Due to these uncertainties commissioning of a
Monte Carlo-based proton beam treatment head might require fine-tuning to ensure accurate
dose distributions in the patient. Moreover, the commissioning process can still be difficult
even if these parameters are precisely known since the integration of temporal geometries in
the Monte Carlo model must precisely match the time-dependent geometrical set-up in the
treatment system if identical beam current modulation functions are used. To help expedite
the commissioning process we have presented a methodology to improve the accuracy of the
SOBP dose distribution by optimizing the Monte Carlo beam current modulation function.
Since the corrections would typically be small (as in our case), the change in the underlying
beam characteristics (e.g. proton energy distribution) is insignificant for patient dose
calculations. This study was based on the treatment head design by IBA (Louvain-la-Neuve,
Belgium) at the Francis H. Burr Proton Therapy Center, nevertheless the basic elements for
SOBP proton beam therapy are similar in most facilities.
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Figure 1.
Schematics of an SOBP proton beam treatment head. (a.) Diagram illustrating (not to scale)
some of the essential components in the treatment head, including (r to l): first scatterers
(FS), range modulator wheel (MW), second scatterer (SS), jaws, ionization chamber, snout,
aperture, and range compensator. (b.) Diagram illustrating the arrangement of steps and the
timing structure of the MW track.
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Figure 2.
The nominal and six modified energy spread functions (ΔE/E) for the beam at nozzle
entrance. The modified energy spread functions were each normalized to the nominal spread
function at 200 MeV. This choice of normalization was based on our prior knowledge that
the SOBP dose distribution for the option corresponding to this energy was uniform.
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Figure 3.
The absolute difference of the modified SOBP range to the nominal range (R) as a function
of change in the density of (a.) Lexan (b.) carbon and (c.) lead for eight of the deliverable
options from the treatment head (see Table 1 for materials defined for each option).
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Figure 4.
The absolute difference of the modified SOBP range to the nominal range (R) as a function
of change in the I-value of (a.) Lexan (b.) carbon and (c.) lead for eight of the deliverable
options from the treatment head (see Table 1 for materials defined for each option).
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Figure 6.
The uniformity plotted as a function of percent change in slope of the energy spread
formula. The uniformity is defined as the percent change in dose from the proximal to distal
portion of the SOBP plateau region.
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Figure 7.
The uniformity plotted as a function of percent change in beam spot size. The uniformity is
defined as the percent change in dose from the proximal to distal portion of the SOBP
plateau region.
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Figure 8.
Plots showing the improvements in the SOBP plateau uniformity once the beam current
modulation functions in the Monte Carlo were optimized. Shown here are eight different
plots (a–h) representing dose distributions produced for the middle options of A1–A8. The
lines labeled I(t) old (dashed lines) represent the dose distributions produced by our Monte
Carlo model from the old beam current modulation function (see equation 3). The lines
labeled I(t) new (solid lines) represent the dose distributions produced by our Monte Carlo
model from the new beam current modulation function (see equation 5). Finally the red
dotted lines represent measured dose distributions. Note that measurement data was
unavailable for options A1 and A2.
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Figure 9.
Energy distributions recorded at the exit of the treatment head produced from I(t) old and
I(t) new for A2 and A6. All distributions are normalized per source proton.
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Figure 10.
Commissioning results presented for Gantry 1. Shown are plots for (a.) the calculated
ranges, (b.) calculated modulations widths, and (c.) uniformity for each of the 24 deliverable
sub-options (three per option A1–A8). The dashed lines indicate the clinical tolerances.
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Figure 11.
Commissioning results presented for Gantry 2. Shown are plots for (a.) the calculated
ranges, (b.) calculated modulations widths, and (c.) uniformity for each of the 18 deliverable
sub-options (three per option B3–B8). The dashed lines indicate the clinical tolerances.
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Table 1
Materials that are present along the proton beam path for each option (A1–A8) of Gantry 1 at Francis H. Burr
Proton Therapy Center. The relevant treatment head components are the FS, MW, and SS.
Material
Lead Lexan Carbon
FS
A1 MW
SS
FS
A2 MW
SS
FS
A3 MW
SS
FS
A4 MW
SS
FS
A5 MW
SS
FS
A6 MW
SS
FS
A7 MW
SS
FS
A8 MW
SS
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Table 2
Nominal densities and I-values for Lexan, carbon, and lead.
density (g/cm3) I-value (eV)
Lexan 1.20 73.1
carbon 1.82 78.0
lead 11.35 823
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